Concepedia

Vincenza Conteduca

VC

69

Publications

4.6K

Citations

33

H-Index

2008

Active since

Affiliations

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Cornell University

Ospedale Santa Chiara

University of Foggia

Vincenza Conteduca is an author at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori specializing in urology, medicine, and oncology.

ORCID

Top concepts

Publications per year

2008–2023

69

Publications

69

Plasma <i>AR</i> and abiraterone-resistant prostate cancer

Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca et al. · Science Translational Medicine · 2015 · 431 citations · Full text

Clinical features of neuroendocrine prostate cancer

Vincenza Conteduca, Clara Oromendia, Kenneth Eng et al. · European Journal of Cancer · 2019 · 350 citations

, , +3

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

Vincenza Conteduca, Daniel Wetterskog, Mansour T. A. Sharabiani et al. · Annals of Oncology · 2017 · 263 citations · Full text

Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus–related mixed cryoglobulinemia: a long-term study

Franco Dammacco, Felicia Anna Tucci, Gianfranco Lauletta et al. · Blood · 2010 · 244 citations · Full text

Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer

Loredana Puca, Katie Gavyert, Verena Sailer et al. · Science Translational Medicine · 2019 · 201 citations · Full text

Rows per page

1–5 of 69